Can-Fite BioPharma (CANF) Registration filing summary

Risk factors and disclosures

• Israeli law restricts exculpation of office holders from liability for breach of duty of loyalty, but allows indemnification for certain liabilities if authorized in the articles of association.

• Indemnification and insurance for directors and officers are subject to limitations, including exclusions for intentional misconduct, breaches of loyalty (unless in good faith), and illegal personal benefit.

• Indemnification agreements are in place for directors and officers, but SEC considers indemnification for Securities Act liabilities unenforceable as a matter of public policy.

Management team and governance

• Executive leadership includes a CEO/CFO, a Chairman/Chief Scientific Officer, and several directors, all of whom have signed the registration statement.

• Directors and officers are covered by liability insurance and have indemnification agreements in place.

Offering details and pricing

• Securities may be offered on a delayed or continuous basis under Rule 415.

• The registration statement may be amended to reflect changes in offering volume or price, provided changes do not exceed 20% of the maximum aggregate offering price.

• The registration covers various securities, including American Depositary Shares, warrants, subscription rights, and units.